Pharma News, 2019

Janssen Oncology has announced key data on Darzalex (daratumumab) for multiple myeloma at this year’s American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

AstraZeneca and Merck & Co/MSD have caused a stir at the ASCO congress in Chicago with new data for their PARP inhibitor Lynparza in pancreatic cancer – a disease which is notoriously tough to t...

(Reuters) - Allergan Plc said on Tuesday it will voluntarily recall and stop the sale of its Biocell textured breast implants in Canada after the country’s health agency suspended the compan...

KENILWORTH, N.

A team of researchers from the University of Minnesota and University of Massachusetts Amherst has discovered new technology that can speed up chemical reactions 10,000 times faster than the current r...

WILMINGTON, Del.

A synthetic, non-intoxicating analogue of cannabidiol (CBD) is effective in treating seizures in rats, according to research by chemists at the University of California, Davis.

HYDERABAD.

Two injected drugs manufactured by an Indian company with a history of sterility problems are being recalled because of microbial contamination.

Italian regulators slapped a warning letter on ICI International Chemical Industry for failing to comply with good manufacturing practices at its Cellole, Italy plant.

In a transcontinental move, a California biotech working on a cell therapy for solid tumors will build its first manufacturing site in Philadelphia.

Piqray (alpelisib) tablets were approved for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advance...